Pharmaceuticals company Natco Pharma announced Q2FY25 results Consolidated total revenue of Rs 1434.9 crore for the Q2FY25 as against Rs 1060.8 crore for the Q2FY24, reflecting a growth of 35.3%. Net profit for the period, on a consolidated basis, was Rs 676.5 crore as against Rs 369.0 crore Q2FY24, showing robust growth of about 83%. The Board of Directors has declared second interim dividend of Rs 1.50 per equity share, for FY25. Result PDF